URTREGER Alejandro Jorge
Opposite effects of protein kinase C beta1 (PKCb1) and PKCe in the metastatic potential of a breast cancer murine model
VALERIA C. GROSSONI; LAURA B. TODARO; MARCELO G. KAZANIETZ; ELISA D. BAL DE KIER JOFFÉ; ALEJANDRO J. URTREGER
BREAST CANCER RESEARCH AND TREATMENT
Lugar: Dordrecht; Año: 2009 vol. 118 p. 469 - 480
In this paper we investigated whether protein kinase C (PKC) b and PKCe, members of the classical and novel PKC family respectively, induce phenotypic alterations that could be associated with tumor progression and metastatic dissemination in a murine model of breast cancer. Stable overexpression of PKCb in LM3 cells altered their ability to proliferate, adhere, and survive, and impaired their tumorigenicity and metastatic capacity. Moreover, PKCb induced the re-expression of fibronectin, an extracellular matrix glycoprotein which loss has been associated with the acquisition of a transformed phenotype in different cell models, and exerted an important inhibition on proteases production, effects that probably impact on LM3 invasiveness and dissemination. Conversely, PKCe overexpression enhanced LM3 survival, anchorage-independent growth, and caused a significant increase in spontaneous lung metastasis. Our results suggest PKCb functions as an inhibitory protein for tumor growth and metastasis dissemination whereas PKCe drives metastatic dissemination without affecting primary tumor growth.